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Abstract 
Background: In an effort to promote greater access to voluntary counseling and testing for HIV, it has become 
practice in many countries, including South Africa, to establish non-medical testing sites and to de-couple HIV testing 
from other medical and mental health care services. While it is well established that HIV infection is associated with 
a range of psychopathology, much of the literature has assumed that it is receipt of an HIV positive diagnosis that 
causes people to become depressed, traumatized, or develop other psychiatric symptoms. Empirical data about the 
baseline psychiatric condition and mental health care needs of persons seeking HIV testing is scarce. Understanding 
the psychological health of persons seeking HIV testing and documenting how psychiatric symptoms develop over 
time following receipt of an HIV positive diagnosis, has important implications for mental health care systems.
Methods: We describe a study protocol to investigate: (1) the level of psychological distress and the prevalence of com-
mon mental disorders among persons seeking HIV testing; (2) the longitudinal development of psychiatric symptoms 
among persons diagnosed with HIV; and (3) the recommendations that can be made for mental health care systems 
to support persons seeking HIV testing and those newly diagnosed with HIV. In this longitudinal study quantitative and 
qualitative data are collected to document participants’ psychiatric symptoms, to determine whether they meet diagnos-
tic criteria for a common mental disorder, and to explore the lived experiences of persons receiving an HIV positive test 
result. Data are collected at three time points; before HIV testing, and then again at 6 and 12 months post-testing.
Discussion: Documenting the prevalence of common mental disorders among persons seeking HIV testing, and 
tracking the psychosocial support needs, psychological adjustment and psychosocial experiences of persons newly 
diagnosed with HIV, has important implications for the delivery of mental health care services and the design of inte-
grated mental health care systems.
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Background
In many public health clinics, HIV testing has become an 
increasingly routine practice. As a result, large numbers 
of persons who have received an HIV positive test result 
and who qualify for treatment have been enrolled in 
antiretroviral therapy (ART) programs. In an effort to 
promote greater access to voluntary counseling and 
testing (VCT) for HIV, it has become practice in many 
countries, including South Africa, to establish non-medi-
cal testing sites and to de-couple HIV testing from other 
medical and mental health care services. Much of the lit-
erature in psychology has assumed that receiving an HIV 
positive test result may precipitate depressive disorders, 
symptoms of post-traumatic stress disorder, or other psy-
chiatric symptoms, and that psychiatric or psychological 
treatment is indicated following a positive test [1–5]. 
However, empirical data about the baseline psychiatric 
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condition of persons seeking HIV testing is absent. It is 
therefore unknown what the prevalence of common 
mental disorders1 is among persons seeking HIV testing 
and whether such individuals are already psychiatrically 
disordered or emotionally distressed prior to receipt of 
their HIV positive result. There are a number of plausible 
rival hypotheses to the dominant view that receipt of an 
HIV positive test result precipitates psychiatric illness, 
including: (1) that rates of psychopathology are high 
among persons seeking HIV testing; and (2) that prior 
mental health problems may be a superior predictor of 
post-HIV psychiatric disturbance than an HIV diagnosis 
in and of itself. The proposed study seeks to test these 
hypotheses. These issues have particular salience in low- 
and middle-income countries, like South Africa, where 
medical resources are scarce and data on the prevalence 
and course of mental disorders are needed to plan effec-
tive and integrated mental health care services.
Depression and anxiety among persons with HIV
Little systematic epidemiological research has been con-
ducted into the prevalence, incidence and duration of 
psychiatric disorders among South African patients liv-
ing with a chronic illness in general, and those living with 
HIV in particular. Yet, as indicated in the international 
literature, disorders such as major depressive disorder 
(MDD) and generalized anxiety disorder (GAD) appear 
to be common among persons living with HIV [6–9]. In 
general, self-report measures have yielded higher preva-
lence rates than those determined by clinician-adminis-
tered structured interviews [10]. However, both of these 
approaches show elevated rates of symptoms of depres-
sion and anxiety among persons living with HIV.
In Uganda, among a sample of 1017 HIV infected per-
sons, 47% scored in the elevated range on the Center 
for epidemiological studies-depression scale, with those 
with low CD4 counts more than twice as likely to report 
elevated depressive symptoms than those with high CD4 
counts [11]. On the other hand, in a comparison between 
HIV positive and negative men, lifetime prevalence 
of MDD were non-significantly different [12]. Among 
the same sample at 2  year follow-up, however, partici-
pants who were symptomatic with HIV disease were 
significantly more likely to have a depressive episode 
than asymptomatic HIV positive persons or HIV nega-
tive controls. Further, a lifetime history of depression 
increased the likelihood of depression post-HIV diag-
nosis. Atkinson et al. [12] concluded from their findings 
1 Common mental disorders are defined, for the purposes of this study, as 
psychiatric conditions which are most frequently associated with HIV infec-
tion. These include depressive disorders, anxiety disorders, trauma-related 
disorders, and substance use disorders.
that symptomatic HIV disease, but not HIV infection 
itself, increases the risk of MDD and that a prior history 
of depression is a major risk factor for depression after 
diagnosis with HIV [12].
Among a sample of 996 Tanzanian women living with 
HIV, more than half reported symptoms of depression 
during the 2  year period in which they were followed 
[13]. Moreover, among this sample, depressive symptoms 
were associated with an elevated risk of disease progres-
sion and mortality, prompting Antelman et al. [13] to call 
for routine screening for depression and psychosocial 
interventions as part of normal HIV care.
Among a sample of 149 South African HIV-infected 
patients, 34.9% had MDD while 21.5% had dysthymic 
disorder as assessed by the MINI International Psychiat-
ric Interview [14]. In a 6 month follow-up study, 26% of 
the sample continued to meet the criteria for a depres-
sive illness [3]. Among another sample of South African 
AIDS patients, 33.4% reported symptoms of anxiety and 
depression, compared with 24.2% in a randomly selected 
community sample [15]. These studies recruited samples 
from peri-urban environments. In a study conducted 
with 465 patients enrolled in HIV care and treatment 
services in a major South African city, the prevalence of 
depression as assessed by the mini-international neu-
ropsychiatric interview (MINI) was 14% [16]. Using the 
composite international diagnostic inventory (CIDI), 
Freeman et  al. [17] found that among 900 HIV positive 
persons, 43.7% had a mental disorder and 11.1% had 
MDD. In these studies, samples were recruited after they 
had received an HIV diagnosis, and it was thus not pos-
sible to determine which participants might have had a 
pre-existing common mental disorder prior to receipt of 
the HIV positive test result.
Post‑traumatic stress disorder and HIV
The rate of posttraumatic stress disorder (PTSD) among 
individuals infected with HIV varies across studies as 
a result of variations in methods of assessment used to 
determine symptomatology, diagnostic criteria used 
to determine caseness, sample characteristics, and the 
diverse definitions of what qualifies as a traumatic event 
[18]. Despite both the varying estimates of PTSD preva-
lence, the available figures suggest that the rate of PTSD 
among persons living with HIV may be higher than in 
the general population [4]. For example, the estimated 
rate of DSM-III-R PTSD determined among an Austral-
ian sample of 61 HIV-positive homosexual and bisex-
ual men was 30% [19]. Similarly, among a sample of 67 
African American HIV-infected women and among an 
American sample of 41 HIV-positive women, the esti-
mated rate of DSM-IV PTSD was 35 and 42%, respec-
tively [20, 21]. Moreover, it was found that the estimated 
Page 3 of 10Bantjes and Kagee  Int J Ment Health Syst  (2018) 12:16 
rate of DSM-IV PTSD among an American sample of 
75 HIV-positive men and women was estimated at 64% 
[22]. Among a South African sample of recently diag-
nosed HIV-positive individuals, an estimated PTSD rate 
of 14.8 and 26% was determined at baseline and follow-
up, respectively [3]. In general, the rate of PTSD reported 
in these studies is higher than that determined in the 
recently conducted South African Stress and Health 
Study [23]. In this nationally representative household 
survey conducted among 4351 South African adults, the 
lifetime prevalence of PTSD was estimated at 2.3% [23].
PTSD may either precede an HIV diagnosis due to 
previously experienced traumatic events, or may emerge 
post-HIV diagnosis as a result of the stress of being 
diagnosed with a life-threatening illness. The disorder 
may also result from the traumatic events experienced 
during the course of the illness. For example, in a study 
conducted among a sample of recently diagnosed HIV-
positive individuals, 14.8% met criteria for PTSD, of 
which 36.4% reported that the index trauma was being 
informed of their HIV-positive diagnosis. Other index 
traumas constituted being raped (22.7%), being robbed or 
assaulted (13.6%), intimate partner violence (9.1%), hav-
ing experienced a serious accident (9.1%) and the death 
of someone close to the individual (9.1%) [3, 14].
The level of PTSD has also been found to be positively 
correlated with the total number of traumatic life events 
experienced by HIV-positive individuals [20, 24]. For 
example, it was found that HIV-positive women who had 
experienced a greater number of traumatic life events had 
a higher percentage of probable full PTSD in comparison 
to those women who had experienced fewer traumatic 
life events [21].
It is our view that HIV does not constitute a stressor 
precipitating PTSD [16]. PTSD is a disorder of memory 
in which the symptoms of avoidance, intrusion, and 
physiologic hyperarousal are anchored to the traumatic 
event that occurred in the past. Concerns associated 
with receipt of an HIV positive test result are typically 
future-oriented, such as impending decline in health sta-
tus, accessing treatment, finding information about the 
condition, and managing problems related to adherence. 
Certainly, distress may be highly common, but this is 
qualitatively different from trauma.
Substance use disorders and HIV
Substance use has been shown to increase the risk of 
HIV infection. Hazardous use of alcohol, illicit drugs and 
intravenous drug use have been linked to the spread of 
the HIV epidemic, particularly in populations which are 
already vulnerable to infection [25, 26]. Evidence sug-
gests that substance use adversely influences the effec-
tiveness of ART and compromises treatment adherence 
among HIV infected persons [27, 28]. Substance use is 
also associated with increased risk of opportunistic infec-
tions, such as hepatitis [29]. Rates of substance use disor-
der (SUD) are higher among HIV infected groups when 
compared to the general population, with nearly 50% of 
persons living with HIV/AIDS reporting current or past 
histories of drug or alcohol disorders [30–32]. It has been 
suggested that treating substance use problems in per-
sons with HIV/AIDS should be an important component 
of integrated HIV treatment, although doing so is not 
without considerable challenges [33].
Common mental disorders among persons seeking HIV 
testing
While there has been considerable research on HIV 
and common mental disorders, little data has been 
accrued about the prevalence of common mental disor-
ders among persons seeking HIV testing. There is also a 
dearth of empirical data showing that receipt of a diag-
nosis of HIV affects the mental health of patients. It is 
commonly assumed that receipt of a positive HIV test 
result is highly emotionally distressing and precipitates 
psychiatric illness. While this may indeed be the case for 
many people, data on psychological reactions of persons 
who receive an HIV positive test result is very sparse. 
The assumption that persons who receive a positive HIV 
test result necessarily experience intense psychologi-
cal distress or psychiatric disturbance is untested in the 
present moment of the HIV pandemic. Some individuals 
may not react as negatively as is commonly assumed for 
at least four reasons. Firstly, in the present era of wide-
spread public awareness programs regarding HIV risk, 
we believe that it is likely that persons who have engaged 
in high risk behavior are likely to have evaluated their risk 
level prior to testing. For this sub-group of the general 
public, a positive HIV test result may confirm what they 
have already suspected. Secondly, in the context of high 
HIV prevalence in many South African communities 
[34, 35] many persons undergoing testing may already 
know others in their social constellation, including sex 
partners, who have tested positive. For these persons, 
a positive HIV test is less likely to be as shocking, trau-
matic, or distressing as has been previously assumed [36]. 
Thirdly, widespread access to antiretroviral treatment 
has changed the texture of the experience of living with 
HIV from impending physical decline and death to that 
of a chronic illness. Fourthly, difficult life circumstances 
characterized by poverty, unemployment, and food inse-
curity make HIV one of a range of life stressors, but not 
necessarily the most salient one in low resource settings. 
While the majority of persons receiving an HIV posi-
tive test result may indeed be distressed, it is likely that 
HIV-related distress may ameliorate over time. Thus it is 
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necessary to document the psychological reactions to an 
HIV diagnosis and to track, over an extended period of 
time, the psychosocial experiences of persons receiving 
an HIV positive result.
In addition to the lack of epidemiological data about 
the prevalence of common mental disorders among per-
sons seeking HIV testing, there have been no attempts 
to validate commonly used psychometric instruments 
among populations of people seeking HIV testing. Simi-
larly, no clinically significant cut-off points have been 
established for commonly used psychiatric symptom 
checklists, among persons seeking HIV testing. This gap 
in the literature hinders efforts to screen for common 
mental disorders among persons seeking HIV testing, 
using instruments such as the Beck depression inventory 
(BDI), Beck anxiety inventory (BAI), Hopkins symptom 
checklist (HSC), posttraumatic stress disorder symptom 
scale (PTSD-SS), alcohol use disorders identification 
test (AUDIT), and drug use disorder identification test 
(DUDIT).
It is within this context that we describe a protocol for 
a study in the Western Cape province of South Africa 
which has the following six objectives:
1. To determine the level of psychological distress (as 
measured by the HSC), and the prevalence of MDD, 
GAD, PTSD, and substance use disorders [as measured 
by the Structured Clinical Interview for DSM-5 (SCID-
5)] among persons who are seeking HIV testing.
2. To determine the sensitivity, specificity, and posi-
tive and negative predictive values of the BDI, BAI, 
PTSD-SS, AUDIT, and DUDIT in predicting MDD, 
GAD, alcohol use disorder and drug use disorder, 
respectively among persons seeking HIV testing.
3. To document fluctuations in the level of psychologi-
cal distress and the development of psychiatric symp-
toms in the 12 month period following receipt of an 
HIV positive diagnosis.
4. To determine if there are significant differences 
between HIV positive and HIV negative individuals, 
on self-report measures of common mental health 
problems, over the course of 1  year following HIV 
testing.
5. To document the lived experience of a group of indi-
viduals from low income settings in the 12  month 
period following receipt of an HIV positive diagno-
sis, in order to learn from them about: the specific 
resource challenges they experience (such as food 
insecurity, housing, employment, and social and fam-
ily support); their psychosocial concerns; their per-
ception of the barriers to receiving appropriate care; 
and their access to health care services and psycho-
social support.
The South African context
Data collected in the South African 2012 HIV Prevalence, 
Incidence and Behaviour Survey, using a nationally rep-
resentative sample of 38,431 respondents from 11,079 
households, reported an HIV prevalence rate of 12.2% 
(95% CI 11.4–13.1), a statistically significant increase 
from 10.6% in 2008 (p < 0.001) [37]. In this household 
survey HIV prevalence rates were found to be higher 
among females (14.4%) than males (9.9%), and adults aged 
25–49  years were most affected (25.2%, 95% CI 23.2–
27.3). ART exposure doubled from 16.6% in 2008 to 31.2% 
in 2012 (p < 0.001), partly as a result of better access to 
VCT. HIV testing is considered to be an important entry 
point to a comprehensive package of care for HIV and 
AIDS prevention and treatment. In response to the HIV 
epidemic, the South African government and numerous 
international aid organizations have invested resources 
in VCT; by 2009 the state had established more than 450 
VCT centers with more than 800 counselors around the 
country [38]. As a result, population-level VCT in South 
Africa is among the highest globally, with a large propor-
tion of South Africans knowing their HIV status [37].
For a range of historic, political and socio-economic 
reasons, South Africa has a poor health system, which 
is characterized by a lack of integration, poor access, 
and serious resource constraints [39, 40]. Primary health 
care remains predominantly biomedical in its orientation 
with a lack of person-centered, integrated health care [41, 
42]. Mental health care resources are particularly scarce 
in South Africa [43], and there is a significant mental 
health treatment gap; an estimated 15.9% of adults with 
mental health problems report receiving treatment [44]. 
A population based study, indicated that the 12-month 
prevalence of DSM-IV disorder was 16.5%, with the 
most common disorders being agoraphobia (4.8%), MDD 
(4.9%), and alcohol abuse or dependence (4.5%) [44].
Methods
This exploratory mixed method study employs quanti-
tative research methods (to elicit measures of psychiat-
ric symptoms) and qualitative methods (to produce a 
description of the lived experiences of individuals who 
receive an HIV positive test result). The research follows 
a longitudinal design. A total of 500 participants will be 
tracked over the course of 1 year. We calculated the mini-
mum sample size needed to provide sufficient power for 
the proposed regression analysis, given the number of 
anticipated predictor variables we intend to include in 
our analysis.
Participants
Participants in the study will be persons who have pre-
sented for HIV testing at non-medical HIV testing sites 
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in peri-urban communities around Cape Town. Only 
individuals who are conversant in English or Afrikaans 
will be recruited. The only exclusion criteria are the pres-
ence of active symptoms of a psychotic illness; being 
under the age of 18; and being unable to give informed 
consent to participate in the study.
Procedure
Persons seeking HIV testing will be invited to enroll in 
the study prior to their HIV test. Once they register at 
the clinic reception, they will be handed a flyer inform-
ing them of the study and inviting them to meet with a 
researcher in a private room. Persons who agree to meet 
with the researcher will be informed about the study 
in person and will be invited to participate in the study 
before undergoing HIV testing. It will be explained to 
participants that the study will involve three data points 
over the course of 1 year and that they will be contacted 
6 months and 1 year later.
Participants will be asked to provide their contact details, 
including mobile telephone numbers, email addresses 
(where possible), and home addresses. Those who agree to 
participate will be asked to complete an informed consent 
form. Participants will receive a grocery voucher worth 
R50 as a token of gratitude for completing the question-
naire battery at each time point as well as payment for 
transport of R20 at the 6 and 12 month time points. They 
will then be asked to participate in a psychiatric interview 
and complete a battery of questionnaires (time 1).
Testing procedures
Participants will proceed with HIV testing and after receiv-
ing their results will receive routine post-test counseling 
provided by the clinic. The HIV status (as determined by 
the HIV test) for each participant will then be recorded.
After 6  months (time 2) all participants will be tele-
phoned and asked to attend a data collection session at 
the testing site. The data collection session will be sched-
uled at specific times so that large groups of participants 
may attend and complete their questionnaires simulta-
neously. Participants will be given a choice of times that 
are most convenient for them. This procedure will be 
repeated again 12 months after HIV testing (time 3).
Data collection
Data will be collected at three points during the study, as 
described below.
Time 1: At the time of HIV testing
1. Data will be collected for the following variables:
2. Demographic variables including employment status, 
housing, food insecurity, and family living circum-
stances.
3. Common mental disorders: MDD, GAD, PTSD, 
and SUD will be assessed using the research version 
of the SCID-5. We will use a SCID-5 that has been 
adapted to comply with the changes to diagnostic 
criteria that came into effect with the introduction of 
the DSM-5.
4. Levels of psychological distress will be assessed 
(using the HSC), and symptoms of MDD, GAD, 
PTSD, and SUD will be assessed (using the BDI, BAI, 
PTSD-SS, AUDIT, and DUDIT). These psychometric 
instruments were selected because they have good 
psychometric properties [45–48], and because they 
are widely used in the field of HIV research, which 
will enable easy comparison of findings in this study 
with the existing literature. During the adminis-
tration of these instruments, participants will be 
reminded that they are being asked to reflect on how 
they felt in the past weeks, and not simply how they 
are feeling right now. Participants with low levels 
of literacy will be assisted in completing the paper-
based self-report questionnaires by a trained data 
collector, who will read the questions to the partici-
pant and record their responses.
Time 2: Six months after HIV testing
Data will be collected for all 500 participants using a 
combination of psychometric instruments and self-
report questionnaires. Participants with low levels of 
literacy will be assisted by trained data collectors in com-
pleting the paper based self-report measures. The follow-
ing data will be collected:
1. Symptoms of depression, anxiety, posttraumatic 
stress, and alcohol and drug use, as measured by the 
BDI, BAI, HSC, PTSD-SS, AUDIT, and DUDIT.
2. Socio-economic circumstances: food security, hous-
ing circumstances, employment status, and access to 
medical treatment.
Qualitative data will also be collected via a semi-struc-
tured interview for a sub-sample of 20 individuals (or 
until saturation) randomly selected from each of the fol-
lowing sub-groups: (1) persons living with HIV who also 
meet the diagnostic criteria for a mental disorder as iden-
tified by data collected at time 2; and (2) persons living 
with HIV who do not meet the diagnostic criteria for a 
mental disorder as identified by data collected at time 2.
During these interviews participants will be asked to 
describe their living circumstances, subjective experience 
of quality of life, general health status, subjective expe-
rience of psychological wellbeing, adjustment to HIV 
diagnosis, disclosure of HIV status in the past 6 months, 
support systems, experience of stigma, coping strategies, 
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access to medical health care (including HIV treatment) 
and psychosocial support services. Participants will also 
be asked where they have accessed medical and psycho-
social care in the preceding 6 months, including contact 
with traditional healers and other complementary and 
alternative health care providers. Participants will be 
asked to describe their current medical and psychosocial 
support needs and their perception of barriers to receiv-
ing care.
Time 3: Twelve months after HIV testing
Data will be collected for the following variables for all 
500 participants using a combination of psychometric 
instruments and self-report questionnaires:
1. Symptoms of depression, anxiety, posttraumatic 
stress, and drug and alcohol use as measured by the 
BDI, BAI, HSC, PTSD-SS, AUDIT and DUDIT.
2. Socio-economic circumstances: Food security, hous-
ing circumstances, employment status, and access to 
medical treatment.
Once again participants with low levels of literacy will 
be assisted in completing the questionnaires.
Qualitative interviews will be conducted with two ran-
domly selected sub groups of 20 participants. The same 
semi-structured interview schedule employed at time 2 
will be utilized to collect qualitative data from: (1) per-
sons living with HIV who also meet the diagnostic crite-
ria for a mental disorder (as assessed at time 3); and (2) 
persons living with HIV who do not meet the diagnostic 
criteria for a mental disorder (as assessed at time 3).
Data analysis
Table  1, below, indicates how data will be analyzed to 
achieve each of the study objectives:
Ethical considerations
Permission to conduct this study has been obtained from 
the Stellenbosch University Health Research Ethics Com-
mittee and institutional permission was obtained from 
the Western Cape Department of Health and non-med-
ical testing sites where data will be collected. Written 
informed consent will be obtained from all participants 
prior to data collection. All data collected will be securely 
stored in a manner that protects participants’ privacy and 
right to confidentiality.
Participants who receive an HIV positive test result 
are likely to become distressed. However, their distress 
is unrelated to study participation and they will receive 
post-test counseling as part of routine care at the testing 
site. Participants identified as having clinical significant 
psychiatric symptoms will be referred for mental health 
services at the clinic or in the community. These referrals 
to mental health services will be handled sensitively to 
minimize the risk of exacerbating psychological distress 
or stigmatizing participants. Typically, access to mental 
health care services in this community is limited, but we 
have secured services for participants who require them 
in community based NGOs and at a local university psy-
chology clinic which provides services to individuals who 
cannot access care in other settings.
There are no major risks associated with this study as 
participants will only be asked to complete a paper and 
pencil questionnaire battery, and answer questions about 
their lived experience and symptoms of psychopathology. 
There is a small possibility that some participants might 
become distressed by completing the questionnaire bat-
tery. These participants will be referred for psychological 
counseling either at the clinic or at a community coun-
seling center.
There are no direct benefits to participants for taking 
part in this study as it is a descriptive and not an inter-
vention study. However, persons who meet the diagnos-
tic criteria for a common mental disorder or who score 
in the clinical range on the self-report measures will be 
referred for mental health services at an appropriate 
community clinic. Further, answering questions related 
to psychological symptoms may alert participants to their 
psychological state and thus increase self-knowledge.
Discussion
The data collected from this project promises to provide 
important information about: (1) the level of psycho-
logical distress and the prevalence of common mental 
disorders among persons seeking HIV testing; (2) the 
sensitivity, specificity, and positive and negative predic-
tive values of commonly used psychometric instruments 
in diagnosing common mental disorders among per-
sons seeking HIV testing; (3) fluctuations in the level of 
psychological distress and psychiatric symptoms in the 
12  month period following an HIV positive diagnosis; 
(4) the extent to which there are significant differences 
between HIV positive and HIV negative individuals, on 
self-report measures of common mental health prob-
lems, over the course of 1 year following HIV testing; and 
(5) the lived experience of a group of individuals from 
low income settings in the 12  month period following 
receipt of an HIV positive diagnosis. The findings have 
the potential to refute or confirm the commonly accepted 
(and as yet untested) idea that receipt of an HIV diagnosis 
is in and of itself a psychological trauma that precipitates 
psychological distress and mental illness. Crucially, the 
findings will also allow us to make empirically supported 
recommendations concerning an integrated package of 
care, including mental health care services, for persons 
Page 7 of 10Bantjes and Kagee  Int J Ment Health Syst  (2018) 12:16 
seeking HIV testing and those newly diagnosed with HIV 
that may enhance engagement with treatment and influ-
ence adherence. Furthermore, establishing the sensitivity, 
specificity, and positive and negative predictive values of 
psychometric instruments (such as the BDI, BAI, PTSD-
SS, AUDIT and DUDIT) for use among persons seek-
ing HIV testing, would be useful for future research and 
clinical practice which entails screening or assessing the 
psychiatric status of persons seeking HIV testing, moni-
toring the trajectory of psychiatric symptoms following 
receipt of an HIV test, and planning appropriate context-
sensitive mental health care services.
In spite of the potential value of this proposed study, 
there are a number of possible limitations. Firstly, the 
study design relies on a convenient self-selected sample 
of people. Although it is acceptable to make use of non-
probability sampling in studies which seek to collect 
information from hard to reach populations, the use of 
such an approach will limit the generalizability of the 
findings [52]. Secondly the diagnostic criteria in the 
SCID-5 are very strict compared to the CIDI. Conse-
quently, we may not diagnose some participants with a 
common mental disorder, even though they would have 
met criteria based on the CIDI. Prevalence estimates 
obtained in this study may thus be under-estimates. 
Thirdly, the SCID is criterion based rather than guide-
line based; there is thus very limited leeway to interpret 
symptoms or exercise clinical judgment in the assess-
ment of participants. This too may lead to under-esti-
mates of prevalence rates. Fourthly, there is a danger that 
Table 1 Data analysis method
Study objective Data analysis method
Objective 1: To determine the level of psychological distress (as measured by 
the HSC), and determine the prevalence of MDD, GAD, PTSD, and SUD (as 
measured by the SCID-5) among persons who are seeking an HIV test
Descriptive statistics will be used to determine the level of psychological 
distress, and prevalence estimates for common mental disorders, using 
a confidence interval of 95%. Rates of comorbidity will also be calcu-
lated to determine the number of individuals who meet diagnostic 
criteria for two or more disorders
Objective 2: To determine the sensitivity, specificity, and positive and 
negative predictive values of the BDI, BAI, PTSD-SS, AUDIT and DUDIT in 
predicting MDD, GAD, PTSD, and SUD, respectively among persons seek-
ing HIV testing
The sensitivity, specificity and positive and negative predictive values of 
self-report measures, will be calculated using receiver operator curve 
(ROC) analysis [49]. By determining the area under the curve for each 
of the self-report measures, we will be able to establish the optimal 
cut-score on the various self-report measures, using the SCID-5 as the 
gold standard
Objective 3: To document fluctuations in the level of psychological distress 
and the development of psychiatric symptoms in the 12 month period 
following receipt of an HIV positive diagnosis
Repeated measures of ANOVA for scores obtained on the HSC, BDI, BAI, 
PTSD-SS, AUDIT, and DUDIT, at times 1, 2 and 3, will be used to establish 
if there are significant fluctuations in levels of psychological distress and 
symptoms of psychiatric disorders over the 12 month period following 
receipt of an HIV positive diagnosis, using a confidence interval of 95%. 
Mixed-effects regression models will be used where appropriate to 
take account of both fixed effects and random effects, on the repeated 
measures of psychiatric symptoms over the three time points [50]
Objective 4: To determine if there are significant differences between HIV 
positive and HIV negative individuals, on self-report measures of common 
mental health problems, over the course of 1 year following HIV testing
A t-test will be used to determine whether a significant difference exists 
between HIV positive and negative persons on the means of their 
scores on the BDI, BAI, PTSD-SS, AUDIT and DUDIT. These comparisons 
will be made at 6 and 12 months after receiving an HIV test
Objective 5: To document the lived experience of a group of individuals 
from low income settings in the 12 month period following receipt of 
an HIV positive diagnosis, in order to learn from them about: the specific 
resource challenges they experience (such as food insecurity, housing, 
employment, and social and family support); their psychosocial concerns; 
their perception of the barriers to receiving appropriate care; and their 
access to health care services and psychosocial support
Interpretive phenomenological analysis (IPA) will be used to elicit a thick 
description of the participants’ lived experiences of adjusting to an HIV 
positive status. Themes will be identified and organized into over-
arching themes which provide insight into how individuals understand, 
adjust to and manage their HIV positive status. Similarly, the interviews 
will be used to provide insight into specific resource challenges they 
experience, their psychosocial concerns, medical and psychosocial sup-
port needs, access to care and perceived barriers to receiving care. The 
themes elicited in the interviews with participants who do not meet 
diagnostic criteria for a common mental disorder, will be compared 
with the themes emerging from the interviews with patients who do 
meet criteria for a common mental disorder. This comparison between 
the lived experience of the two groups will hopefully provide insight 
into why some individuals develop psychiatric symptoms following 
receipt of an HIV positive test result, while others do not. We have cho-
sen to use IPA to analyze the qualitative data as this is a well-established 
and structured approach which is well suited to exploring people’s lived 
worlds; this method has also been extensively used in health psychol-
ogy research to document patients’ experience of illness and recovery 
[51]
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in both the structured clinical interviews and the qualita-
tive interviews, participants might be influenced by the 
demand characteristics of the interview situation, thus 
endorsing symptoms and/or editing what they report, in 
order to appear compliant or meet the expectations of the 
interviewer. The risk of this is compounded by the fact 
that participants receive compensation for taking part in 
the interviews. Finally, the study design requires assess-
ments at three time points, using a wide variety of instru-
ments. This will be time consuming, costly and could be 
onerous for participants, which raises questions about 
the feasibility of the study. It is, however, necessary to 
include this full battery of instruments in order to meet 
the objectives of the study and provide a comprehensive 
assessment of the mental health care needs of persons 
seeking HIV testing and those newly diagnosed with HIV. 
We intend trying to overcome this potential limitation by 
providing incentives to participants for completing ques-
tionnaires, and arranging the follow up testing to be done 
in groups at times convenient to participants.
We anticipate that there might well be difficulties with 
follow-up and attrition, given the longitudinal research 
design of the study and the intention to collect data 6 and 
12 months post HIV testing. It is difficult to know what 
the rate of attrition will be and how difficult it may be to 
trace participants for follow-up. Attrition in longitudinal 
studies is a well-documented problem in epidemiologi-
cal research [53, 54], particularly in low- and middle-
income countries [55]. Even though we intend to collect 
contact numbers and residential addresses for partici-
pants, it is well known that people living in low resource 
communities in South Africa are very mobile; they move 
homes frequently and change their cell phone numbers 
periodically.
Conclusion
Contact with the health care system while seeking HIV 
testing provides an opportunity for psychological inter-
vention and the early detection and treatment of psy-
chopathology. Hitherto this opportunity for intervention 
has been missed, in part because HIV testing has been 
uncoupled from the provision of other medical and psy-
chosocial support services in countries like South Africa. 
In an effort to provide greater access to HIV testing in 
South Africa, a large number of non-medical HIV testing 
sites have been established, thus contributing to and per-
petuating an unintegrated health care system. This lack 
of integration of mental health care services within HIV 
testing sites, is premised on the untested assumption that 
psychological distress is a consequence of receiving an 
HIV positive diagnosis. Conducting studies like the one 
described in this protocol could help to establish if there 
is a need for better integration of mental health services, 
especially screening for mental disorders and referral 
of those persons who are in need of services, as part of 
efforts to strengthen mental health care systems in low- 
and middle-income countries. Understanding the trajec-
tory of psychological adjustment following receipt of an 
HIV diagnosis will also help plan better mental health 
care services to support newly diagnosed individuals.
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